BioCentury
ARTICLE | Top Story

UTHR drops Ketotop on Phase III data

December 8, 2000 8:00 AM UTC

United Therapeutics (UTHR) discontinued development of Ketotop, its transdermal ketoprofen delivery patch, which was in Phase III testing for osteoarthritis of the knee, after the compound failed to r...